2015, Number 4
Next >>
Ann Hepatol 2015; 14 (4)
Hepatology highlights
Majumdar A, Tsochatzis E
Language: English
References: 6
Page: 440-441
PDF size: 73.76 Kb.
Text Extraction
Melo-Villar L,
et al.
Hypovitaminosis D and its relation to demographic
and laboratory data among hepatitis C patients
Melo-Villar L,
et al. The potential detrimental
effect of vitamin D deficiency on sustained virological
response (SVR) rates after antiviral therapy for
chronic hepatitis C infection has been a topic of controversy.
REFERENCES
Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK. Vitamin D level and sustained virologic response to interferon- based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. J Hepatol 2014; 61: 1247-52.
García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a metaanalysis. Hepatology 2014; 60: 1541-50.
Roulot D1, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, Le Clesiau H, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community- based population aged over 45 years. Gut 2011; 60: 977-84.
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50.
Musso G1, Gambino R, Cassader M, Pagano G. Metaanalysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-49.
Armstrong MJ1, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59: 1174-97.